优势价格
快速发货
品质保证
技术支持
400-920-2911 sales@csnpharm.cn
PLK
| 货号 | 产品名 | CAS号 | 信息 |
|---|---|---|---|
| CSN23160 | TC-S 7005 | 1082739-92-1 | TC-S 7005 is a Polo-like kinases (Plks) inhibitor with IC50s of 4 nM, 24 nM and 214 nM for Plk2, Plk3, and Plk1, respectively[1]. |
| CSN16924 | SBE13 HCl | 1052532-15-6 | SBE13 HCl is a potent and selective PLK1 inhibitor with IC50 of 0.2 nM while 875 nM and 66 μM for PLK3 and PLK2. SBE 13 could also induce cell cycle arrest, reduce cell proliferation with EC50 of 5-60 µM, and induce apoptosis in a broad range of human cancer cell lines. |
| CSN15803 | Rigosertib Sodium (Random Configuration) | 1225497-78-8 | Rigosertib Sodium (Random Configuration) is a non-ATP-competitive inhibitor of PLK1 with IC50 of 9 nM in a cell-free assay. It shows 30-fold greater selectivity against Plk2 and no activity to Plk3. |
| CSN18210 | Poloxin | 321688-88-4 | Poloxin is a non-ATP competitive Polo-like Kinase 1 (PLK1) inhibitor that targets the polo-box domain. |
| CSN18151 | LFM-A13 | 244240-24-2 | LFM-A13 is a potent and selective inhibitor of Btk with IC50 of 17.2 μM and also inhibits PLK3 with IC50 of 7.2 μM. |
| CSN16519 | HMN-214 | 173529-46-9 | HMN-214 is a potent PLK1 inhibitor an average IC50 of 0.12 μM, and a prodrug of HMN-176, which alters the cellular spatial orientation of Plk1. |
| CSN19103 | HMN-176 | 173529-10-7 | HMN-176 is the active derivative of HMN-214 which can alter the cellular spatial orientation of Plk1. |
| CSN12710 | GW843682X | 660868-91-7 | GW843682X is a selective PLK1 and PLK3 inhibitor with IC50s of 2.2 nM (PLK1) and 9.1 nM (PLK3) and displays > 100-fold selectivity over ~30 other kinases tested including cdk1 and cdk2. |
| CSN22785 | Cyclapolin 9 | 40533-25-3 | Cyclapolin 9 is a selective, ATP-competitive polo-like kinase 1 (PLK1) inhibitor with IC50 of 500 nM. |
